--- name: asplos-workflow description: Use when planning an ASPLOS campaign across the two-deadline cycle — sequencing evidence building, the September 9, 2026 submission gate, author-response windows, the December 21 notification, Major Revision resubmission six weeks later, artifact evaluation, and the April 2027 conference in Crete, with owners per risk. --- # ASPLOS Workflow An ASPLOS campaign is a pipeline with two entry gates per edition and a revision side-channel, not a single deadline sprint. All dates below are the verified 2027 cycle (CFP and conference site, checked 2026-07-08); reopen the official pages before committing a team to any of them. ## The 2027 cycle as a calendar | Gate | April cycle | September cycle | |---|---|---| | Full-paper deadline (11:59 PM AoE) | April 15, 2026 — **passed** | **September 9, 2026 — the live gate** | | Author response | July 6-9, 2026 — **open this week** (as of 2026-07-08) | December 1-4, 2026 | | Notification | July 27, 2026 | December 21, 2026 | | Major Revision due | camera-ready deadline, 6 weeks after notification | camera-ready deadline, 6 weeks after notification | | Conference | April 11-15, 2027, Heraklion, Crete, Greece | same | There is no separate abstract deadline in 2027, and no mid-year third round — the edition moved from three deadlines to two. Missing September means waiting for the next edition's first gate. ## Working backward from September 9, 2026 A credible countdown for a systems paper with hardware-dependent evidence: ```text T-10 weeks (by ~Jul 1) Freeze the claim list; run asplos-topic-selection; choose evidence instruments (silicon / FPGA / simulator). T-8 weeks Evaluation infrastructure done: baselines building, workloads chosen, simulator configs pinned. T-6 weeks First full results sweep; kill or descope claims the data will not carry. Start the two-page draft NOW — it is the part rapid review actually reads. T-4 weeks Full draft; internal red-team against the rapid-review question set; ablations running. T-2 weeks Freeze experiments. Citation-format pass (full names, no "et al.", DOIs). Anonymity sweep. T-1 week HotCRP entry created; PDF uploaded; co-author sign-off. T-0 Sep 9, 11:59 PM AoE HotCRP status shows *complete*, not draft. ``` ## Role assignments that prevent known failures - **Two-page owner** — one author owns pages 1-2 as a standalone artifact and rehearses them against `asplos-writing-style`; rapid review reads nothing else. - **Evidence-integrity owner** — keeps the experiment matrix (claims × platforms × baselines) current so the rebuttal window never requires new runs under pressure. - **Compliance owner** — template, 11-page geometry, citation full-name rule, GenAI disclosure, HotCRP fields; format violations risk rejection without review. - **Response owner** — reserves the response window dates (Dec 1-4 for the September cycle) on every author's calendar at submission time, not after reviews arrive. ## Branch planning at notification (December 21, 2026) 1. **Accept** → switch to `asplos-camera-ready` immediately; camera-ready lands ~6 weeks out, and artifact evaluation (`asplos-artifact-evaluation`) runs in parallel with its own appendix and deadlines (2027 AE calendar 待核实). 2. **Major Revision** → treat as a funded contract, not a consolation: the revision is due at the camera-ready deadline and *counts as a submission*; scope revision work to exactly what the decision letter requires, tracked in a change log that will become the resubmission note. 3. **Reject at rapid review** → the diagnosis is almost always positioning: the first two pages did not establish the intersection or the evidence. Fix framing before considering a new venue. 4. **Reject after full review** → mine the reviews for the evidence matrix, then re-run `asplos-topic-selection`; some full-review rejects are strong ISCA, SOSP, or PLDI papers mis-aimed at the intersection. ## Cross-edition cautions - The two-deadline structure is itself new for 2027; do not assume it for 2028. - ASPLOS logistics genuinely change year to year — the 2025 edition (30th, Rotterdam) ran jointly with EuroSys; 2026 (31st) was standalone in Pittsburgh; 2027 is in Crete. Travel, visa, and registration planning must restart per edition (fees and attendance rules for 2027: 待核实). - Program leadership rotates every edition; there is no standing editorial memory to appeal to. A policy answer from a previous year's chairs is expired. ## Hardware lead times are schedule items Systems evidence has procurement physics that a paper calendar must absorb: - Cluster or testbed reservations for the T-8 to T-2 sweep window book out weeks ahead; reserve at claim-freeze time, not first-results time. - FPGA synthesis iterations and simulator calibration runs are days-long serial steps — one redesign late in the countdown costs a week, not an evening. - Access to pre-production parts (new memory devices, engineering samples) often comes with NDA review of the paper text; start that review before T-4 or it becomes the critical path. ## Between notification and Crete An accepted September-cycle paper has a compressed post-decision runway: camera-ready and any Major Revision work land ~6 weeks after December 21 — squarely across the holiday break, which the six-week plan must acknowledge — followed by artifact evaluation, then travel logistics for an April conference in Greece (visa timelines for some team members exceed the gap; start at notification). Presentation format, registration requirements, and speaker obligations for 2027 were 待核实 at pack-check time: read the acceptance email before assigning the talk. ## Pipelining across gates Teams running multiple projects should treat the two gates as a pipeline: a paper that misses the September evidence bar can target the next edition's first gate with its evaluation matrix already built, while the response and revision windows of a September submission land in December-February — plan author bandwidth so a Major Revision does not collide with the next project's deadline sprint. One person cannot own the revision of paper A and pages 1-2 of paper B in the same six weeks. ## Output format ```text [Cycle chosen] September 2026 / next edition (reason) [Countdown health] on-track items · at-risk items with dates [Owners] two-page / evidence / compliance / response — names attached? [Branch plans] accept · major-revision · rapid-reject · full-reject, one line each [Calendar holds] Dec 1-4 response window + 6-week revision block reserved? Y/N [Facts to re-verify] ```